This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Magrath, I, Adde, M, Shad, A, Venzon, D, Seibel, N, Gootenberg, J, Neely, J, Arndt, C, Nieder, M, Jaffe, E, Wittes, RA & Horak, ID Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol, (1996). 14, 925–934.
Lee, EJ, Petroni, GR, Schiffer, CA, Freter, CE, Johnson, JL, Barcos, M, Frizzera, G, Bloomfield, CD & Peterson, BA Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of Cancer and Leukemia Group B Study 9251. J Clin Oncol, (2001). 19, 4014–4022.
Kantarjian, HM, O’Brien, S, Smith, TL, Cortes, J, Giles, FJ, Beran, M, Pierce, S, Huh, Y, Andreeff, M, Koller, C, Ha, CS, Keating, MJ, Murphy, S & Freireich, EJ Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia. J Clin Oncol, (2000). 18, 547–561.
Zhang, W, Ohnishi, K, Shigeno, K, Fujisawa, S, Naito, K, Nakamura, S, Takeshita, K, Takeshita, A & Ohno, R The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia, (1998). 12, 1383–1391.
Zhu, XH, Shen, YL, Jing, YK, Cai, X, Jia, PM, Huang, Y, Tang, W, Shi, GY, Sun, YP, Dai, J, Wang, ZY, Chen, SJ, Zhang, TD, Waxman, S, Chen, Z & Chen, GQ Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst, (1999). 91, 772–778.
Macpherson, N, Lesack, D, Klasa, R, Horsman, D, Connors, JM, Barnett, M & Gascoyne, RD Small noncleaved, non-Burkitt's (Burkitt-like) lymphoma: cytogenetics predict outcome and reflect clinical presentation. J Clin Oncol, (1999). 17, 1558–1567.
van Besien, K, Rodriguez, A, Tomany, S, Younes, A, Donato, M, Sarris, A, Giralt, S, Mehra, R, Andersson, B, Gajewski, J, Champlin, R & Cabanillas, F Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival. Bone Marrow Transplant, (2001). 27, 397–404.
Li, YS, Zhang, TD & Li, CW Traditional Chinese and western medicine in the treatment of 27 patients with malignant lymphoma. Zhonghua zhong liu za zhi (Chinese Journal of Oncology), (1988). 10, 61–62.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ravandi, F., van Besien, K. Clinical activity of arsenic trioxide in Burkitt-like lymphoma. Leukemia 17, 271–272 (2003). https://doi.org/10.1038/sj.leu.2402735
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402735